NEUROTEZ

Neurotez, Inc. is a private corporation whose primary goal is to develop a Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk.

Also known as: Neurotez, Inc.

Primary location: Bridgewater United States